Skip to Content

Clindamycin Injection

Last Updated: July 3, 2017
Status: Current

Clindamycin Injection

Products Affected - Description
  • Clindamycin phosphate injection, Alvogen
    150 mg/mL, 2 mL ADD-Vantage vial, 25 count (NDC 47781-0462-69)
    150 mg/mL, 4 mL ADD-Vantage vial, 25 count (NDC 44781-0463-69)
    150 mg/mL, 6 mL ADD-Vantage vial, 25 count (NDC 47781-0464-69)

     
    Clindamycin phosphate injection, Fresenius Kabi
    150 mg/mL, 2 mL vial, 25 count (NDC 63323-0282-02)
150 mg/mL, 6 mL vial, 25 count (NDC 63323-0282-06)
150 mg/mL, 60 mL vial, 1 count (NDC 63323-0282-60)
 
Clindamycin phosphate injection, Sagent
150 mg/mL, 2 mL vial, 25 count (NDC 25021-0115-02)
Reason for the Shortage
    • Akorn did not provide a reason for the shortage.
    • Alvogen has clindamycin injection available.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Pfizer has Cleocin available.
    • Sagent has clindamycin injection available.
    • Sandoz has clindamycin injection available.
Available Products
  • Cleocin injection, Pfizer

150 mg/mL, 2 mL ADD-Vantage vial, 25 count (NDC 00009-6582-01)
150 mg/mL, 2 mL vial, 25 count (NDC 00009-0870-26)
150 mg/mL, 4 mL ADD-Vantage vial, 25 count (NDC 00009-3124-03)
150 mg/mL, 4 mL vial, 25 count (NDC 00009-0775-26)
150 mg/mL, 6 mL ADD-Vantage vial, 25 count (NDC 00009-3447-03)
150 mg/mL, 6 mL vial, 25 count (NDC 00009-0902-18)
150 mg/mL, 60 mL bulk vial, 5 count (NDC 00009-0728-09)
300 mg/50 mL premixed bags, 24 count (NDC 00009-3381-02)
600 mg/50 mL premixed bags, 24 count (NDC 00009-3375-02)
900 mg/50 mL premixed bags, 24 count (NDC 00009-3382-02)
 
Clindamycin phosphate injection, Akorn
300 mg/50 mL, premixed bottle, 1 count (NDC 17478-0120-50)
600 mg/50 mL, premixed bottle, 1 count (NDC 17478-0121-50)
900 mg/50 mL, premixed bottle, 1 count (NDC 17478-0122-50)
 
Clindamycin phosphate injection, Alvogen
150 mg/mL, 2 mL vial, 25 count (NDC 47781-0459-68)
150 mg/mL, 4 mL vial, 25 count (NDC 47781-0460-68)
150 mg/mL, 6 mL vial, 25 count (NDC 44781-0461-68)
150 mg/mL, 60 mL bulk vial, 1 count (NDC 47781-0465-70)
 
Clindamycin phosphate injection, Fresenius Kabi
150 mg/mL, 4 mL vial, 25 count (NDC 63323-0282-04)
 
Clindamycin phosphate injection, Sagent
150 mg/mL, 4 mL vial, 25 count (NDC 25021-0115-04)
150 mg/mL, 6 mL vial, 25 count (NDC 25021-0115-06)
150 mg/mL, 60 mL bulk vial, 1 count (NDC 25021-0115-51)
 
Clindamycin phosphate injection, Sandoz
300 mg/50 mL premixed container, 24 count (NDC 00781-3288-09)
600 mg/50 mL, premixed container, 24 count (NDC 00781-3289-09)
900 mg/50 mL, premixed container, 24 count (NDC 00781-3290-09)

Estimated Resupply Dates

    • Alvogen has clindamycin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of 3rd quarter 2017.
    • Fresenius Kabi has clindamycin 150 mg/mL 2 mL, 6 mL, and 60 mL vials on back order and the company cannot estimate a release date.
    • Sagent has clindamycin 150 mg/mL 2 mL vials available with an expiration date of October 2017.

Updated

July 3, June 6, May 11, April 13, March 24, February 23 and 7, January 12, 2017; December 2, November 11, August 16, June 9, April 14, February 24, January 27, 14 and 6, 2016; December 15, November 5 and 4, October 19, September 17, July 21, June 25, April 30 and 17, March 30, 23 and 9, February 12, January 14, 2015; December 29, 22, 17 and 5, November 24 and 4, October 23 and 10, September 24, 12 and 3, August 15 and 8, June 12, May 23 and 5, April 23 and 7, March 26, 11 and 5, February 21 and 10, January 24 and 14, 2014; December 27 and 18, November 21 and 6, October 23, 14 and 7, September 17, August 28 and 7, July 3, June 13, 2013, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide